GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GE HealthCare Technologies Inc (NAS:GEHC) » Definitions » Altman Z2-Score

GE HealthCare Technologies (GE HealthCare Technologies) Altman Z2-Score : 1.12 (As of Apr. 30, 2024)


View and export this data going back to 2022. Start your Free Trial

What is GE HealthCare Technologies Altman Z2-Score?

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

GE HealthCare Technologies has a Altman Z2-Score of 1.12, indicating it is in Grey Zones. This implies that GE HealthCare Technologies is in some kind of financial stress. If it is below 1.1, the company may face bankrupcy risk.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for GE HealthCare Technologies's Altman Z2-Score or its related term are showing as below:

GEHC' s Altman Z2-Score Range Over the Past 10 Years
Min: 1.12   Med: 1.45   Max: 2.11
Current: 1.12

During the past 5 years, GE HealthCare Technologies's highest Altman Z2-Score was 2.11. The lowest was 1.12. And the median was 1.45.


GE HealthCare Technologies Altman Z2-Score Historical Data

The historical data trend for GE HealthCare Technologies's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GE HealthCare Technologies Altman Z2-Score Chart

GE HealthCare Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z2-Score
- - 2.11 1.45 1.12

GE HealthCare Technologies Quarterly Data
Dec19 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.45 1.13 1.27 1.39 1.12

Competitive Comparison of GE HealthCare Technologies's Altman Z2-Score

For the Health Information Services subindustry, GE HealthCare Technologies's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GE HealthCare Technologies's Altman Z2-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, GE HealthCare Technologies's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where GE HealthCare Technologies's Altman Z2-Score falls into.



GE HealthCare Technologies Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

GE HealthCare Technologies's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.0132+3.26*0.0409+6.72*0.0894+1.05*0.2837
=1.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2023:
Total Assets was $32,454 Mil.
Total Current Assets was $9,410 Mil.
Total Current Liabilities was $8,981 Mil.
Retained Earnings was $1,326 Mil.
Pre-Tax Income was 609 + 636 + 570 + 546 = $2,361 Mil.
Interest Expense was -131 + -138 + -137 + -136 = $-542 Mil.
Total Liabilities was $25,144 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(9410 - 8981)/32454
=0.0132

X2=Retained Earnings/Total Assets
=1326/32454
=0.0409

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(2361 - -542)/32454
=0.0894

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(7133 - 0)/25144
=0.2837

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

GE HealthCare Technologies has a Altman Z2-Score of 1.12 indicating it is in Grey Zones.


GE HealthCare Technologies  (NAS:GEHC) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


GE HealthCare Technologies Altman Z2-Score Related Terms

Thank you for viewing the detailed overview of GE HealthCare Technologies's Altman Z2-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


GE HealthCare Technologies (GE HealthCare Technologies) Business Description

Traded in Other Exchanges
Address
500 West Monroe Street, Chicago, IL, USA, 60661
GE HealthCare Technologies Inc is a globally medical technology, pharmaceutical diagnostics, and digital solutions innovator company. It has four operating segments; Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). It earns a majority of its revenue from the Imaging segment.
Executives
Kevin Michael O'neill officer: CEO, PDx 500 W. MONROE STREET, CHICAGO IL 60661
Roland Rott officer: CEO, Ultrasound 500 W. MONROE STREET, CHICAGO IL 60661
James Saccaro officer: Chief Financial Officer ONE BAXTER PARKWAY, DEERFIELD IL 60015
Jan Makela officer: CEO, Imaging 500 W. MONROE STREET, CHICAGO IL 60661
Taha Kass-hout officer: Chief Technology Officer 500 W. MONROE STREET, CHICAGO IL 60661
Kenneth R. Stacherski officer: Ch. Supply Chain & Serv. Ofc. 500 W MONROE, CHICAGO IL 60661
Culp H Lawrence Jr director GENERAL ELECTRIC COMPANY, ONE FINANCIAL CENTER, SUITE 3700, BOSTON MA 02111
William J Stromberg director 100 E. PRATT STREET, BALTIMORE MD 21202
Thomas J. Westrick officer: CEO, Patient Care Solutions 500 W. MONROE STREET, CHICAGO IL 60661
Yang Watkin Phoebe L. director C/O DOXIMITY, INC., 500 THIRD STREET, SAN FRANCISCO CA 94107
Rodney F Hochman director 21919 30TH DR SE, BOTHELL WA 98021
Tomislav Mihaljevic director ONE FINANCIAL CENTER, SUITE 3700, BOSTON MA 02111
Lloyd Jr Howell director 8283 GREENSBORO DRIVE, MCLEAN VA 22102
Anne T Madden director C/O HONEYWELL 300 S. TRYON STREET, CHARLOTTE NC 28202
Frank R Jimenez officer: GC & Corporate Secretary GE HEALTHCARE TECHNOLOGIES INC., 500 W. MONROE ST., CHICAGO IL 606061